American Bio Medica Corporation (ABMC)
OTCMKTS: ABMC · Delayed Price · USD
0.0003
0.00 (0.00%)
Apr 15, 2024, 9:30 AM EDT - Market open
American Bio Medica Statistics
Total Valuation
ABMC has a market cap or net worth of $14,430.
| Market Cap | 14,430 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ABMC has 48.10 million shares outstanding.
| Shares Outstanding | 48.10M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.02% |
| Owned by Institutions (%) | n/a |
| Float | 35.55M |
Valuation Ratios
The trailing PE ratio is 0.00.
| PE Ratio | 0.00 |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -37.08 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $20,688 |
| Profits Per Employee | $227,125 |
| Employee Count | 16 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.07M |
| Effective Tax Rate | -132.35% |
Stock Price Statistics
The stock price has decreased by -97.79% in the last 52 weeks. The beta is 1.97, so ABMC's price volatility has been higher than the market average.
| Beta (1Y) | 1.97 |
| 52-Week Price Change | -97.79% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 88.72 |
| Average Volume (30 Days) | 2,038 |
Short Selling Information
The latest short interest is 5,863, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 5,863 |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.02% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, ABMC had revenue of $331,000 and earned $3.63 million in profits. Earnings per share was $0.08.
| Revenue | 331,000 |
| Gross Profit | -66,000 |
| Operating Income | -1.45M |
| Pretax Income | 1.56M |
| Net Income | 3.63M |
| EBITDA | -1.39M |
| EBIT | -1.41M |
| Earnings Per Share (EPS) | $0.08 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity / Book Value | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | -974,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | -974,000 |
| FCF Per Share | -$0.02 |
Margins
Gross margin is -19.94%, with operating and profit margins of -439.27% and 1,097.89%.
| Gross Margin | -19.94% |
| Operating Margin | -439.27% |
| Pretax Margin | 472.51% |
| Profit Margin | 1,097.89% |
| EBITDA Margin | -419.34% |
| EBIT Margin | -425.68% |
| FCF Margin | -294.26% |
Dividends & Yields
ABMC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 25,183.65% |
| FCF Yield | -6,749.83% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |